Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Surbhi Warrior"'
Publikováno v:
Cancer Medicine, Vol 11, Iss 24, Pp 4954-4965 (2022)
Abstract Background Accurate diagnostic biomarker testing is crucial to treatment decisions in breast cancer. Biomarker testing is performed on core needle biopsies (CNB) and is often repeated in the surgical specimen (SS) after resection. As differe
Externí odkaz:
https://doaj.org/article/e731e81538ff49b092098380493e0cdd
Autor:
Surbhi Warrior, Elizabeth Behrens, Joshua Thomas, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
Publikováno v:
TH Open, Vol 05, Iss 03, Pp e415-e419 (2021)
Externí odkaz:
https://doaj.org/article/eaa4d56f66d5492298446f2de65e22cf
Autor:
Parameswaran Venugopal, Elizabeth Behrens, Surbhi Warrior, Joshua Thomas, Sefer Gezer, Shivi Jain
Publikováno v:
TH Open, Vol 05, Iss 03, Pp e415-e419 (2021)
TH Open: Companion Journal to Thrombosis and Haemostasis
TH Open: Companion Journal to Thrombosis and Haemostasis
Background: COVID-19 has developed into a global pandemic with respiratory compromise and systemic coagulopathy causing significant morbidity and mortality. Methods: A retrospective analysis was performed on all COVID-19 patients hospitalized between
Publikováno v:
Cancers. 15:2908
Patients with HER2-positive breast cancer have seen improved survival and outcomes over the past two decades. As patients live longer, the incidence of CNS metastases has increased in this population. The authors’ review outlines the most current d
Publikováno v:
Cancer Research. 81:PS2-34
Accurate diagnostic biomarker testing, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (Her2) expression profile, is crucial to appropriate management decisions in breast cancer. Receptor sta
Publikováno v:
Thrombosis Research
Publikováno v:
Blood
Background The Coronavirus disease-2019 (COVID-19) is a global pandemic caused by novel coronavirus SARS-CoV-2. Acute respiratory and renal failure as well as systemic coagulopathy are critical aspects of the morbidity and mortality in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9801d2f00070b7f69e0dcc8780eb3cf
https://doi.org/10.21203/rs.3.rs-194846/v1
https://doi.org/10.21203/rs.3.rs-194846/v1
Autor:
Parameswaran Venugopal, Elizabeth Behrens, Surbhi Warrior, Xavier Pombar, Joshua Thomas, Sefer Gezer, Shivi Jain
Publikováno v:
Blood
Background Coronavirus disease-2019 (COVID-19) has become a global pandemic causing respiratory compromise, coagulopathy and renal failure in severe cases. Studies demonstrate a high incidence of venous thromboembolism (VTE), up to 69% in patients wi
Autor:
Surbhi Warrior, Elizabeth Behrens, Sefer Gezer, Priya Rajakumar, Shivi Jain, Joshua Thomas, Parameswaran Venugopal
Publikováno v:
Blood
Background The Coronavirus disease-2019 (COVID-19) is a global pandemic. Acute respiratory compromise and systemic coagulopathy cause significant morbidity and mortality. Venous thromboembolism (VTE), which encompasses both deep vein thrombosis (DVT)
Publikováno v:
Blood
Background The virus SARS-CoV-2, which causes COVID-19 has rapidly spread into a global pandemic. In critically ill patients with the disease, common symptoms include sepsis, severe pneumonia with acute respiratory distress syndrome (ARDS), and compl